跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rexulti - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rexulti
Approved
STANDARD
Rexulti
Korea Otsuka Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a08e3a381c47a482
Company
Korea Otsuka Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
a08e3a381c47a482
Drug Approval Philippines Name
Rexulti
Product Name
Rexulti
Registration Number
DR-XY48696
Brand Name
Rexulti
Generic Name
Brexpiprazole
Dosage Form
Film-Coated Tablet
Dosage Strength
2 mg
Manufacturer
Korea Otsuka Pharmaceutical Co., Ltd.
Importer
Otsuka (Philippines) Pharmaceutical, Inc.
Distributor
Otsuka (Philippines) Pharmaceutical, Inc.
Company Detail Path
/organization/korea-otsuka-pharmaceutical-co-ltd
Importer Detail Path
/organization/otsuka-philippines-pharmaceutical-inc
Distributor Detail Path
/organization/otsuka-philippines-pharmaceutical-inc
Issuance Date
13 April 2023
Expiry Date
13 April 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a08e3a381c47a482
Type
Standard
Back to Philippines FDA Approvals